Get the Stockscreener App
0.37
2.63%
-0.01
Aspira Womens Health Inc stock is traded at $0.37, with a volume of 59,740.
It is down -2.63% in the last 24 hours and down -50.67% over the past month.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
See More
Previous Close:
$0.38
Open:
$0.3847
24h Volume:
59,740
Relative Volume:
0.68
Market Cap:
$6.72M
Revenue:
$9.15M
Net Income/Loss:
$-16.18M
P/E Ratio:
-0.2102
EPS:
-1.76
Net Cash Flow:
$-15.92M
1W Performance:
-1.88%
1M Performance:
-50.67%
6M Performance:
-68.10%
1Y Performance:
-91.42%
1-Day Range:
$0.325
$0.3884
1-Week Range:
$0.29
$0.41
52-Week Range:
$0.29
$5.00
Aspira Womens Health Inc Stock (AWH) Company Profile
Name
Aspira Womens Health Inc
Sector
Industry
Phone
512-519-0400
Address
12117 BEE CAVES ROAD BUILDING THREE, AUSTIN
Compare AWH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AWH
Aspira Womens Health Inc
|
0.3884 | 6.72M | 9.15M | -16.18M | -15.92M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
569.31 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
206.89 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
145.24 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
457.80 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
207.08 | 36.97B | 15.32B | 1.41B | 1.96B | 7.62 |
Aspira Womens Health Inc Stock (AWH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-22 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-29-21 | Initiated | Truist | Buy |
| Jan-29-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-30-20 | Initiated | William Blair | Outperform |
Aspira Womens Health Inc Stock (AWH) Latest News
Ratios in Focus: Analyzing Aspira Women’s Health Inc (AWH)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Ratio Analysis: Unpacking Gap, Inc (GAP)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Deeper Dive: Understanding Redwire Corporation (RDW) Through its Various Ratios - The Dwinnex
Aspira Women's Health appoints new CEO and VP of Finance - MSN
Aspira Women's Health Inc. Announces Chief Executive Officer Changes -January 31, 2025 at 06:15 am EST - Marketscreener.com
Aspira Women’s Health appoints new CEO and VP of Finance By Investing.com - Investing.com Nigeria
SEC Form FWP filed by Aspira Women's Health Inc. - Quantisnow
Aspira Women’s Health Announces Key Leadership Changes - TipRanks
AWH Stock Plummets to 52-Week Low of $0.38 Amid Market Struggles - Investing.com UK
Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations - ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
$31.46 Billion Women's Health Diagnostics Industry Outlook, - GlobeNewswire
Bioxytran (OTCMKTS:BIXT) to Release Cancer Preprint Revealing Potential Immunotherapy EnhancementOn January 10, 2025, Bioxytran Inc., a clinical-stage biotechnology company focused on developing oral and intravenous drugs for various conditions, a - Defense World
Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com - Defense World
Aspira Women’s Health Appoints Mike Buhle as SVP of Commercial Operations - citybiz
Aspira Women's Health Inc. Appoints Mike Buhle as SVP of Commercial Operations - Marketscreener.com
Aspira Women's Health Strengthens Leadership Team with Key Commercial and Financial Appointments - StockTitan
Aspira Women's Health CFO resigns, CEO assumes duties - Investing.com
Aspira Women’s Health CFO Resignation and Leadership Update - TipRanks
AWH Stock Surges Over 5% Amid Mixed Analyst Ratings - GuruFocus.com
Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com - Defense World
Aspira Women's Health in Shelton to use $10M grant to create blood test to detect endometriosis - CTPost
Aspira Women’s Health (NASDAQ:AWH) Earns Hold Rating from Analysts at StockNews.com - Defense World
Organon & Co. (NYSE: OGN) Reduces Board Size Following Resignation of Director - Defense World
Aspira Women's Health's SWOT analysis: stock outlook amid diagnostic growth - Investing.com India
Aspira Women's Health CEO steps down, interim appointed By Investing.com - Investing.com Canada
Aspira Women’s Health CEO Transition and Leadership Change - TipRanks
AWHAspira Women's Health Inc. Latest Stock News & Market Updates - StockTitan
Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer - citybiz
Aspira Women’s Health Appoints Dr. Sandra Milligan as Interim CEO - citybiz
Akari Therapeutics Strengthens Leadership: Former CFO Returns After $50M Fundraising Success - StockTitan
Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO - The Manila Times
Aspira Women's Health CEO Steps Down Following OvaWatch Launch, $10M Research Grant Success - StockTitan
StockNews.com Begins Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World
Aspira Women's Health's SWOT analysis: stock faces growth potential amid financial hurdles - Investing.com Nigeria
CURE® SURVEY UNVEILS WHAT INVESTORS LOOK FOR IN FUNDING WOMEN'S HEALTH - PR Newswire
AWS supports ARPA-H Sprint for Women’s Health to advance crucial research and solutions - AWS Blog
Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award - The Manila Times
Aspira Women's Health Secures $2M ARPA-H Grant for AI-Powered Endometriosis Test - StockTitan
StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World
Aspira: Q3 Earnings Snapshot - New Haven Register
Aspira Women's Health Inc. (AWH) reports earnings - Quartzy
Aspira Women's Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Aspira Womens Health Inc Stock (AWH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aspira Womens Health Inc Stock (AWH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Fralick Celeste Rachelle | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,000 |
0 |
50,665 |
| Parnell Winfred | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,157 |
0 |
60,897 |
| Cavanaugh Stefanie L. | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,937 |
0 |
66,851 |
| Ragard John Phillip | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
4,844 |
0 |
125,047 |
| Milligan Sandra | Interim CEO & President |
Dec 31 '24 |
Option Exercise |
0.00 |
20,000 |
0 |
20,000 |
| Vos Ellen O'Connor | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,312 |
0 |
63,364 |
| Vos Ellen O'Connor | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,313 |
0 |
58,052 |
| Cavanaugh Stefanie L. | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,938 |
0 |
60,914 |
| Parnell Winfred | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,156 |
0 |
55,740 |
| Herchuk Jannie Prestridge | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
8,438 |
0 |
57,190 |
8.22%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):